Found: 7
Select item for more details and to access through your institution.
Magnetic Resonance Imaging Improves Cerebrospinal Fluid Biomarkers in the Early Detection of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 2, p. 351, doi. 10.3233/JAD-2009-0968
- By:
- Publication type:
- Article
Hippocampal glucose metabolism predicts cognitive decline and correlates to disease progression in the ADNI population
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P3-067: MRI brain atrophy and CSF biomarkers predict decline to Alzheimer's disease in mild cognitive impairment
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2011, v. 31, n. 2, p. 671, doi. 10.1038/jcbfm.2010.145
- By:
- Publication type:
- Article
Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer’s disease.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 9, p. 1467, doi. 10.1007/s00259-007-0406-5
- By:
- Publication type:
- Article
Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 9, p. 1471, doi. 10.2967/jnumed.116.187211
- By:
- Publication type:
- Article
Multicenter Standardized <sup>18</sup>F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 3, p. 390, doi. 10.2967/jnumed.107.045385
- By:
- Publication type:
- Article